The healthcare sector has been severely impacted by the coronavirus (COVID-19) outbreak. Industry associations, governments, and medical institutes are imposing travel restrictions, and as a result, some scheduled meetings and conferences face postponement or cancellation. The spread of COVID-19 has forced organizations to rethink their plans. HCPs are already at a higher risk of COVID-19 […]

PD-1 inhibitors have become a mainstay of treatment for many cancers in recent years. However, while these agents are associated with a robust response in some patients, the majority of patients will progress. Several trials have evaluated potential combination strategies to bolster responses to PD-1 inhibitors, but there is no clear consensus in this area. […]

According to an analysis of the PREVAIL and AFFIRM clinical trials, development of new bone lesions in chemotherapy-naive men with metastatic castration-resistant prostate cancer (mCRPC) who are stable or responding to enzalutamide is a form of pseudoprogression that does not necessarily impact long-term outcomes. The study evaluated outcomes in 1672 patients treated with enzalutamide on […]

Each year the American Society of Clinical Oncology (ASCO) releases a report highlighting the greatest clinical advances in cancer research and treatment for the past year. In the most recent report, released in early February, ASCO president Howard “Skip” Burris III, MD, named the refinement of surgical treatment of cancer as the Advance of the […]

The major news in recent months has been the emergence and spread of a novel coronavirus, COVID-19 (formerly known as 2019nCoV). To help clinicians sort fact from fiction regarding this new virus and infection, a primer was recently published in JAMA. This provides background on the origin and spread of COVID-19, common signs and symptoms […]

The global pharma market has experienced unprecedented growth over the last several years. Growth is expected to continue, with the global market exceeding $1.5 trillion by 2023. In the years ahead, pharma spending will be primarily driven by developed markets and newly launched innovative products. However, growth may slow in some regions due to changes […]

While children and older adults with acute lymphoblastic leukemia (ALL) are treated at pediatric and adult cancer centers respectively, adolescents and young adults (AYAs; 15 to 39 years) represent a unique patient group that can be treated in either setting. According to a recent report evaluating patterns of care, only 32.3% of AYA patients are […]

Racial disparities in cancer treatment and outcomes are common and well-documented. According to a new study published in JAMA Oncology, minority patients with cancer also experience disparities in the cultural competency of their physician, including access to physicians who understand their culture. The study evaluated patient data from 2244 adult cancer survivors participating in the […]

Effective clinical research requires a continuous stream of data, but gathering real-world data isn’t always easy. It can be particularly tricky for pharmaceutical manufacturer researchers to connect with practicing oncologists. Community oncologists have many demands on their time and may not be available to participate in clinical research when you need them most. However, their […]

Emerging Oncology Trends Dramatic advances within the last decade have reshaped the global oncology market. A record number of new cancer drugs have received regulatory approval. Some of these treatments, such as immunotherapies, have permanently altered the way we approach cancer treatment. Yet while the global oncology market has enjoyed many triumphs, the industry continues […]